Bazarbachi A - Search Results

1

A Critical Review of Animal Models Used in Acute Myeloid Leukemia Pathophysiology.

Skayneh H, Jishi B, Hleihel R, Hamieh M, Darwiche N, Bazarbachi A, El Sabban M, El Hajj H. Skayneh H, et al. Among authors: bazarbachi a. Genes (Basel). 2019 Aug 13;10(8):614. doi: 10.3390/genes10080614. Genes (Basel). 2019. PMID: 31412687 Free PMC article. Review.

2

Human T-cell lymphotropic virus type 1-transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells.

El-Sabban ME, Merhi RA, Haidar HA, Arnulf B, Khoury H, Basbous J, Nijmeh J, de Thé H, Hermine O, Bazarbachi A. El-Sabban ME, et al. Among authors: bazarbachi a. Blood. 2002 May 1;99(9):3383-9. doi: 10.1182/blood.v99.9.3383. Blood. 2002. PMID: 11964307 Free article.

3

Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells.

Nasr R, Rosenwald A, El-Sabban ME, Arnulf B, Zalloua P, Lepelletier Y, Bex F, Hermine O, Staudt L, de Thé H, Bazarbachi A. Nasr R, et al. Among authors: bazarbachi a. Blood. 2003 Jun 1;101(11):4576-82. doi: 10.1182/blood-2002-09-2986. Epub 2003 Jan 30. Blood. 2003. PMID: 12560223 Free article.

4

Signet ring-like light chain myeloma with systemic spread.

Haidar JH, Bazarbachi A, Nasr MR, El-Sabban ME, Daher R. Haidar JH, et al. Among authors: bazarbachi a. Eur J Haematol. 2003 Apr;70(4):249-50. doi: 10.1034/j.1600-0609.2003.00048.x. Eur J Haematol. 2003. PMID: 12656751

5

N-(4-hydroxyphenyl)retinamide induces growth arrest and apoptosis in HTLV-I-transformed cells.

Darwiche N, Hatoum A, Dbaibo G, Kadara H, Nasr R, Abou-Lteif G, Bazzi R, Hermine O, de Thé H, Bazarbachi A. Darwiche N, et al. Among authors: bazarbachi a. Leukemia. 2004 Mar;18(3):607-15. doi: 10.1038/sj.leu.2403245. Leukemia. 2004. PMID: 14712289

6

Human T-cell lymphotropic virus type I-infected cells extravasate through the endothelial barrier by a local angiogenesis-like mechanism.

Bazarbachi A, Abou Merhi R, Gessain A, Talhouk R, El-Khoury H, Nasr R, Gout O, Sulahian R, Homaidan F, de Thé H, Hermine O, El-Sabban ME. Bazarbachi A, et al. Cancer Res. 2004 Mar 15;64(6):2039-46. doi: 10.1158/0008-5472.can-03-2390. Cancer Res. 2004. PMID: 15026341

7

Ceramide inhibits IL-2 production by preventing protein kinase C-dependent NF-kappaB activation: possible role in protein kinase Ctheta regulation.

Abboushi N, El-Hed A, El-Assaad W, Kozhaya L, El-Sabban ME, Bazarbachi A, Badreddine R, Bielawska A, Usta J, Dbaibo GS. Abboushi N, et al. Among authors: bazarbachi a. J Immunol. 2004 Sep 1;173(5):3193-200. doi: 10.4049/jimmunol.173.5.3193. J Immunol. 2004. PMID: 15322180

8

New therapeutic approaches for adult T-cell leukaemia.

Bazarbachi A, Ghez D, Lepelletier Y, Nasr R, de Thé H, El-Sabban ME, Hermine O. Bazarbachi A, et al. Lancet Oncol. 2004 Nov;5(11):664-72. doi: 10.1016/S1470-2045(04)01608-0. Lancet Oncol. 2004. PMID: 15522654 Review.

9

Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma.

Nasr R, El-Sabban ME, Karam JA, Dbaibo G, Kfoury Y, Arnulf B, Lepelletier Y, Bex F, de Thé H, Hermine O, Bazarbachi A. Nasr R, et al. Among authors: bazarbachi a. Oncogene. 2005 Jan 13;24(3):419-30. doi: 10.1038/sj.onc.1208212. Oncogene. 2005. PMID: 15543232

10

Human T-cell lymphotropic virus type I-transformed T-cells have a partial defect in ceramide synthesis in response to N-(4-hydroxyphenyl)retinamide.

Darwiche N, Abou-Lteif G, Najdi T, Kozhaya L, Tayoun AA, Bazarbachi A, Dbaibo GS. Darwiche N, et al. Among authors: bazarbachi a. Biochem J. 2005 Nov 15;392(Pt 1):231-9. doi: 10.1042/BJ20050578. Biochem J. 2005. PMID: 16086670 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

393 results

Search Page